The prevalence rate of chronic hepatitis B and C among pulmonary TB patients Source: Annual Congress 2008 - Tuberculosis in immigrants, disadvantaged populations, elderly, HIV-seropositives and in other risk groups Year: 2008
Clinical-evolutive aspects of pulmonary tuberculosis at patients with chronic hepatitis Source: Annual Congress 2007 - Tuberculosis Year: 2007
Results of treatment of patients with pulmonary tuberculosis combined with HIV infection and hepatitis Source: International Congress 2018 – Tuberculosis comorbidities Year: 2018
The impact of bedaquiline and delamanid containing regimens on liver function in patients multi-infected with pulmonary DR-TB, HIV and viral hepatitis Source: International Congress 2019 – Tuberculosis: treatment and management Year: 2019
Clinical and morphological outcomes of pulmonary tuberculosis concurrent with chronic hepatitis Source: Eur Respir J 2006; 28: Suppl. 50, 13s Year: 2006
Features the effectiveness of the treatment of moxifloxacin in patients with co-infections tuberculosis/HIV and hepatitis B,and/or C Source: Virtual Congress 2020 – Tuberculosis and comorbidities Year: 2020
Prevalence of hepatitis c virus infection among patients with COPD Source: Annual Congress 2009 - COPD: exacerbation and clinical problems Year: 2009
Risk of adverse effects of antitubercular drugs in patients with pulmonary tuberculosis and low active viral hepatitis C and other digestive tract diseases Source: Annual Congress 2008 - Tuberculosis in immigrants, disadvantaged populations, elderly, HIV-seropositives and in other risk groups Year: 2008
Influence of viral hepatitis and anti-TB drugs on hepatocyte disfunction in patients with MDR/XDR tuberculosis Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis Year: 2021
The role of hepatitis C virus infections in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 333s Year: 2005
Prevention of drug-induced liver injury in patients with pulmonary tuberculosis and chronic hepatitis C Source: International Congress 2019 – Clinical problems from non-malignant pleural disease to hypoventilation Year: 2019
Factors effecting the hepatic enzyme levels in tuberculosis patients with toxic hepatitis Source: Eur Respir J 2006; 28: Suppl. 50, 73s Year: 2006
Clinical characteristics and treatment response of pulmonary cryptococcosis in HIV negative patients Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections Year: 2009
Epstein-Barr virus specific antibodies in patients with idiopathic pulmonary fibrosis and presence of EBV in respiratory tract: reactivation of infection? Source: Eur Respir J 2005; 26: Suppl. 49, 333s Year: 2005
The incidence of hepatitis C virus in patients with lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 94s Year: 2006
Relation between level of acute phase proteins and efficiency of treatment in patients with pulmonary tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 8s Year: 2006
Interstitial lung involvement in patients with chronic HCV hepatitis Source: Eur Respir J 2006; 28: Suppl. 50, 744s Year: 2006
Evaluation of D-dimer levels in patients with active pulmonary tuberculosis and latent tuberculosis infection Source: Eur Respir J 2006; 28: Suppl. 50, 164s Year: 2006
Prevalence of CNS lesions in patients with pulmonary tuberculosis and HIV infection Source: International Congress 2019 – Tuberculosis: from diagnosis to complications Year: 2019
Diagnosis of latent tuberculosis infection in patients with chronic liver disease undergoing liver transplantation: performance of the new IFN-γ-based assays Source: Eur Respir J 2007; 30: Suppl. 51, 752s Year: 2007